Xeltis

This early study tests a new synthetic blood vessel (XABG) for coronary artery bypass surgery in 20 people with multi-vessel heart disease. The graft is designed to work like a natural artery. Researchers are checking if it stays open and is safe in the first 30 days. This is a f…

This study is testing a new type of graft (called aXess) for people with end-stage kidney disease who need hemodialysis but can't have a standard fistula. The graft is made of a biodegradable material that may help reduce complications. About 140 adults will be enrolled to see if…